232 related articles for article (PubMed ID: 16127052)
21. [Alpha interferon, antiviral proteins and their value in clinical medicine].
Chieux V; Hober D; Chehadeh W; Wattré P
Ann Biol Clin (Paris); 1999; 57(6):659-66. PubMed ID: 10572214
[TBL] [Abstract][Full Text] [Related]
22. MxA and PKR expression in chronic hepatitis C.
Giannelli G; Guadagnino G; Dentico P; Antonelli G; Antonaci S
J Interferon Cytokine Res; 2004 Nov; 24(11):659-63. PubMed ID: 15684819
[TBL] [Abstract][Full Text] [Related]
23. [Interferon alpha, gamma, omega before and during treatment of chronic hepatitis C with pegylated interferon alpha and ribavirin].
Bolewska B; Czajka A; Moczko J; Juszczyk J
Przegl Epidemiol; 2007; 61(4):755-63. PubMed ID: 18572508
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis C virus replication is inhibited by 22beta-methoxyolean-12-ene-3beta, 24(4beta)-diol (ME3738) through enhancing interferon-beta.
Hiasa Y; Kuzuhara H; Tokumoto Y; Konishi I; Yamashita N; Matsuura B; Michitaka K; Chung RT; Onji M
Hepatology; 2008 Jul; 48(1):59-69. PubMed ID: 18459156
[TBL] [Abstract][Full Text] [Related]
25. Synthesis of IFN-beta by virus-infected chicken embryo cells demonstrated with specific antisera and a new bioassay.
Schwarz H; Harlin O; Ohnemus A; Kaspers B; Staeheli P
J Interferon Cytokine Res; 2004 Mar; 24(3):179-84. PubMed ID: 15035851
[TBL] [Abstract][Full Text] [Related]
26. Correlation of interferon-induced expression of MxA mRNA in peripheral blood mononuclear cells with the response of patients with chronic active hepatitis C to IFN-alpha therapy.
Antonelli G; Simeoni E; Turriziani O; Tesoro R; Redaelli A; Roffi L; Antonelli L; Pistello M; Dianzani F
J Interferon Cytokine Res; 1999 Mar; 19(3):243-51. PubMed ID: 10213463
[TBL] [Abstract][Full Text] [Related]
27. Intrahepatic MxA and PKR protein expression in chronic hepatitis C virus infection.
MacQuillan GC; de Boer WB; Platten MA; McCaul KA; Reed WD; Jeffrey GP; Allan JE
J Med Virol; 2002 Oct; 68(2):197-205. PubMed ID: 12210408
[TBL] [Abstract][Full Text] [Related]
28. Interferon-inducible Mx gene expression in cotton rats: cloning, characterization, and expression during influenza viral infection.
Pletneva LM; Haller O; Porter DD; Prince GA; Blanco JC
J Interferon Cytokine Res; 2006 Dec; 26(12):914-21. PubMed ID: 17238834
[TBL] [Abstract][Full Text] [Related]
29. Neutralizing antibodies to interferon-α and circulating interferon in patients with chronic hepatitis C non-responding to pegylated interferon plus ribavirin re-treated by pegylated interferon-α-2a and ribavirin (ANRS HC16 GAMMATRI substudy).
Halfon P; Pérusat S; Bourlière M; Bronowicki JP; Trimoulet P; Benhamou Y; Leroy V; Marcellin P; Foucher J; Penaranda G; Chêne G; Couzigou P;
J Med Virol; 2010 Dec; 82(12):2027-31. PubMed ID: 20981789
[TBL] [Abstract][Full Text] [Related]
30. Correlation between the anti-virus-induced cytopathic effect activity of interferon-alpha subtypes and induction of MxA protein in vitro.
Schanen C; Chieux V; Lobert PE; Harvey J; Hober D
Microbiol Immunol; 2006; 50(1):19-24. PubMed ID: 16428869
[TBL] [Abstract][Full Text] [Related]
31. Cloning and sequence analyses of cDNAs for interferon- and virus-induced human Mx proteins reveal that they contain putative guanine nucleotide-binding sites: functional study of the corresponding gene promoter.
Horisberger MA; McMaster GK; Zeller H; Wathelet MG; Dellis J; Content J
J Virol; 1990 Mar; 64(3):1171-81. PubMed ID: 2154602
[TBL] [Abstract][Full Text] [Related]
32. A novel, quantitative bioassay for type I interferon using a recombinant indicator cell line.
Lleonart R; Näf D; Browning H; Weissmann C
Biotechnology (N Y); 1990 Dec; 8(12):1263-7. PubMed ID: 1366960
[TBL] [Abstract][Full Text] [Related]
33. Differential transcriptional expresión of the polymorphic myxovirus resistance protein A in response to interferon-alpha treatment.
Fernández-Arcás N; Blanco A; Gaitán MJ; Nyqvist M; Alonso A; Reyes-Engel A
Pharmacogenetics; 2004 Mar; 14(3):189-93. PubMed ID: 15167707
[TBL] [Abstract][Full Text] [Related]
34. Association of TRIM22 with the type 1 interferon response and viral control during primary HIV-1 infection.
Singh R; Gaiha G; Werner L; McKim K; Mlisana K; Luban J; Walker BD; Karim SS; Brass AL; Ndung'u T;
J Virol; 2011 Jan; 85(1):208-16. PubMed ID: 20980524
[TBL] [Abstract][Full Text] [Related]
35. A comparison of interferon-Con1 with natural recombinant interferons-alpha: antiviral, antiproliferative, and natural killer-inducing activities.
Ozes ON; Reiter Z; Klein S; Blatt LM; Taylor MW
J Interferon Res; 1992 Feb; 12(1):55-9. PubMed ID: 1573283
[TBL] [Abstract][Full Text] [Related]
36. A whole blood immunoassay for the interferon-inducible human Mx protein.
Towbin H; Schmitz A; Jakschies D; Von Wussow P; Horisberger MA
J Interferon Res; 1992 Apr; 12(2):67-74. PubMed ID: 1578188
[TBL] [Abstract][Full Text] [Related]
37. [Genetic polymorphisms of MxA protein and eIF-2a-reg2 and their responses to interferon treatment in patients with chronic hepatitis B].
Huang YX; Ma LN; Chen XY; Li Z; Huang YL; Shen CL; Ma B
Zhonghua Gan Zang Bing Za Zhi; 2007 Mar; 15(3):187-91. PubMed ID: 17407708
[TBL] [Abstract][Full Text] [Related]
38. Induction of MxA gene expression by influenza A virus requires type I or type III interferon signaling.
Holzinger D; Jorns C; Stertz S; Boisson-Dupuis S; Thimme R; Weidmann M; Casanova JL; Haller O; Kochs G
J Virol; 2007 Jul; 81(14):7776-85. PubMed ID: 17494065
[TBL] [Abstract][Full Text] [Related]
39. Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection: roles of MxA, OAS-1 and PKR.
Knapp S; Yee LJ; Frodsham AJ; Hennig BJ; Hellier S; Zhang L; Wright M; Chiaramonte M; Graves M; Thomas HC; Hill AV; Thursz MR
Genes Immun; 2003 Sep; 4(6):411-9. PubMed ID: 12944978
[TBL] [Abstract][Full Text] [Related]
40. Respiratory syncytial virus strain A2 is resistant to the antiviral effects of type I interferons and human MxA.
Atreya PL; Kulkarni S
Virology; 1999 Sep; 261(2):227-41. PubMed ID: 10497108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
